PROXEON BIOSYSTEMS ApS: Financial statements 2024
CVR: 26848024
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PROXEON BIOSYSTEMS ApS (CVR 26848024) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 3,703,000 compared with DKK -7,432,000 the year before. Equity in the 2024 report amounted to DKK 383,640,000. The solvency ratio was 97.2%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 3,703,000
- Equity
- DKK 383,640,000
- Total Assets
- DKK 394,523,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 0 | 3.7 mio. | 383.6 mio. | - |
| 2023 | - | 36.9 mio. | -7.4 mio. | 379.9 mio. | - |
| 2022 | - | 39.4 mio. | 30.4 mio. | 387.4 mio. | - |
| 2021 | - | 30.9 mio. | 23.9 mio. | 357 mio. | - |
| 2020 | - | 20.7 mio. | 15.7 mio. | 333 mio. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PROXEON BIOSYSTEMS ApS has published its annual report for 2023. Gross profit came to DKK 36,919,000, and the net result was DKK -7,432,000.
About PROXEON BIOSYSTEMS ApS
PROXEON BIOSYSTEMS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Lie. The board consists of Piet Van der Zande (chair), Anthony Hugh Smith and Simon Lie. The company is owned by NUNC A/S. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity in the 2025 report amounted to DKK 386,590,000.